Yoav Shetzer
Rehovot, M, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitors.
Journal: International journal of cancer
Published: August 04, 2016
Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.
Journal: Cold Spring Harbor perspectives in medicine
Published: May 29, 2016
Rescue of embryonic stem cells from cellular transformation by proteomic stabilization of mutant p53 and conversion into WT conformation.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 30, 2014
The paradigm of mutant p53-expressing cancer stem cells and drug resistance.
Journal: Carcinogenesis
Published: March 25, 2014
The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele.
Journal: Cell death and differentiation
Published: October 21, 2013
p53 counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition.
Journal: Cell death and differentiation
Published: September 22, 2012
Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species.
Journal: Journal of cell science
Published: August 18, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026